Ana L. Sanabria-Alcaraz
Albacete, CM 02008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
TACkling Cancer by Targeting Selective Protein Degradation.
Journal: Pharmaceutics
Published: September 04, 2023
Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates.
Journal: Frontiers in immunology
Published: September 29, 2021
Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast Cancer.
Journal: Cancers
Published: January 08, 2021
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
Journal: International journal of molecular sciences
Published: November 18, 2020
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors.
Journal: Frontiers in oncology
Published: November 01, 2019
Transcriptome evolution from breast epithelial cells to basal-like tumors.
Journal: Oncotarget
Published: August 02, 2017
Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer.
Journal: Molecular cancer therapeutics
Published: March 11, 2017
Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.
Journal: Oncotarget
Published: October 19, 2016
DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer.
Journal: Oncotarget
Published: May 23, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026